Our results suggest that MSC-sEVs have potentially protective effects against acute DOX-induced cardiomyopathy, through mechanisms that upregulate surviving expression via regulating Akt-Sp1/p53 signaling pathway. The gene discussed is TP53; the disease is cardiomyopathy.